| Please check with your doctor or call 1-855-HCH-HOPE (424-4673) to find out if you qualify.
|
Trial #
|
Trial Sub-type
|
Title
|
|
ECOG E 1505
NCI
|
Patients must have undergone complete resection of their NSCLC (stage IB [≥ 4 cm] - IIIA [T2-3N0, T1-3N1, T1-3N2]) prior to enrollment.
|
Phase III Randomized Study of Adjuvant Chemotherapy With or Without Bevacizumab in Patients With Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer
|
|
ECOG E 5508
NCI
|
IIIB or IV Stage Non-Squamous Non-Small Cell Lung Cancer
|
Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed or Both Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Stage Non-Squamous Non-Small Cell Lung Cancer
|
|
SWOG S0819
NCI
|
Stage IV
NSCLC
|
A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
|
|
CALGB 140503
|
Non-Small Cell Lung Cancer
|
A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small (<=2 cm) Peripheral Non-Small Cell Lung Cancer
|
|
